|
Nov 8
|
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
|
|
Nov 8
|
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
|
|
Nov 7
|
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
|
|
Nov 2
|
KORU Medical Systems to Participate in Upcoming Investor Conferences
|
|
Aug 9
|
KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook
|
|
Aug 8
|
KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference
|
|
Jul 10
|
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
|